Macro & Micro-Test touts early pregnancy test with 5 mIU/mL sensitivity

Macro & Micro-Test said its hCG rapid test is designed to help women confirm pregnancy earlier and get timely medical follow-up, including evaluation for ectopic pregnancy. The company also highlighted global certifications, multiple test formats and results in 5 to 10 minutes.

Why it matters: - Early pregnancy testing can speed up medical decisions, including follow-up for ectopic pregnancy, which can cause life-threatening internal bleeding if not found promptly. - Earlier confirmation can help patients start prenatal care, folic acid supplementation and lifestyle changes during the first trimester. - The World Health Organization includes hCG testing in its List of Essential In Vitro Diagnostics, underscoring the test’s role in women’s healthcare.

What happened: - Macro & Micro-Test promoted its hCG rapid test products for early pregnancy detection. - The company said the products are available in midstream, cassette and strip formats. - The company said the tests are designed to provide results in 5 to 10 minutes. - The release was dated July 20, 2026, in Rudong, Jiangsu, China.

The details: - The test is described as detecting hCG levels as low as 5 mIU/mL. - The midstream version includes an anti-slip handle and a 6 mm wide test strip. - The products are said to have a shelf life of up to 24 months at room temperature. - The tests are approved by NMPA, FDA and CE IVDR. - Manufacturing is said to follow ISO 9001:2015, ISO 13485:2016 and MDSAP requirements. - The release says highly sensitive tests may detect pregnancy as early as 8 to 9 days after ovulation. - Testing around the expected menstrual period, about 14 days after ovulation, is described as more reliable. - The release says accuracy exceeds 99% when testing is done about 7 days after a missed period. - A positive home test should be followed by blood hCG testing and ultrasound at a healthcare facility for confirmation. - The release advises using morning urine, checking the expiration date, reading instructions carefully, following the specified procedure and reading results within the stated 5 to 10 minute window.

Between the lines: - The message frames early pregnancy testing as both a consumer product issue and a clinical safety issue. - The emphasis on ectopic pregnancy points to the limits of home testing: a positive result confirms hCG, not the pregnancy location. - The company is positioning the test on speed, sensitivity and regulatory credentials rather than price.

What's next: - Patients who get a positive home result are expected to seek clinical confirmation and follow-up. - Macro & Micro-Test is likely to keep marketing the product across markets that recognize NMPA, FDA and CE IVDR-linked quality claims. - The company says reliable diagnostics are part of supporting women’s health and informed choices at every stage of life.

The bottom line: - Macro & Micro-Test is pitching early pregnancy testing as an early warning tool, a care-planning tool and a safety step for detecting possible complications sooner.